Article Versions Notes

Imai T, Ngo-Thanh H, Suzue K, Shimo A, Nakamura A, Horiuchi Y, Hisaeda H, Murakami T. Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria. Vaccines. 2022; 10(5):762. https://doi.org/10.3390/vaccines10050762

Imai, Takashi, Ha Ngo-Thanh, Kazutomo Suzue, Aoi Shimo, Akihiro Nakamura, Yutaka Horiuchi, Hajime Hisaeda, and Takashi Murakami. 2022. "Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria" Vaccines 10, no. 5: 762. https://doi.org/10.3390/vaccines10050762

Imai, T., Ngo-Thanh, H., Suzue, K., Shimo, A., Nakamura, A., Horiuchi, Y., Hisaeda, H., & Murakami, T. (2022). Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria. Vaccines, 10(5), 762. https://doi.org/10.3390/vaccines10050762